Rocket Pharmaceuticals (RCKT) Preferred Shares (2017)
Rocket Pharmaceuticals' (RCKT) quarterly Preferred Shares came in at $16.1 million in Q4 2017.
Rocket Pharmaceuticals (RCKT) Preferred Shares (2017) Analysis & Trends
Rocket Pharmaceuticals has disclosed Preferred Shares across 1 years of filings, most recently posting $16.1 million for Q4 2017.
- Preferred Shares for Q4 2017 came in at $16.1 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2017 was $16.1 million (changed N/A YoY), and the FY2017 annual result was $16.1 million, changed N/A from the prior year.
- Preferred Shares came in at $16.1 million for Q4 2017 at Rocket Pharmaceuticals.
- In the past five years, Preferred Shares ranged from a high of $16.1 million in Q4 2017 to a low of $16.1 million in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Rocket Pharmaceuticals | 296.03 Mn | 296.03 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 16.06 Mn |